Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response

Abstract Identifying biomarkers of antidepressant response may advance personalized treatment of major depressive disorder (MDD). We aimed to identify longitudinal changes in gene expression associated with response to antidepressants in a sample of MDD patients treated with escitalopram. Patients (...

Full description

Bibliographic Details
Main Authors:	Laura M. Fiori, Massimiliano Orri, Zahia Aouabed, Jean François Théroux, Rixing Lin, Corina Nagy, Benicio N. Frey, Raymond W. Lam, Glenda M. MacQueen, Roumen Milev, Daniel J. Müller, Sagar V. Parikh, Susan Rotzinger, Rudolf Uher, Jane A. Foster, Sidney H. Kennedy, Gustavo Turecki
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-08-01
Series:	Translational Psychiatry
Online Access:	https://doi.org/10.1038/s41398-021-01564-8

Similar Items

Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report
by: Giorgia Caspani, et al.
Published: (2021-07-01)

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants
by: Rixing Lin, et al.
Published: (2023-07-01)

Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report
by: Antoine Yrondi, et al.
Published: (2021-09-01)

Alterations in the neural correlates of affective inhibitory control following cognitive behavioral therapy for depression: A Canadian biomarker integration network for depression (CAN-BIND) study
by: Prabhjot Dhami, et al.
Published: (2022-12-01)

Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1.
by: John-Jose Nunez, et al.
Published: (2021-01-01)

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
by: Juan Pablo Lopez, et al.
Published: (2017-05-01)

An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report
by: Jee Su Suh, et al.
Published: (2020-01-01)

Rhythmicity of sleep and clinical outcomes in major depressive disorder: A CAN-BIND-1 report
by: Manish Dama, et al.
Published: (2022-07-01)

Multi-omic modeling of antidepressant response implicates dynamic immune and inflammatory changes in individuals who respond to treatment.
by: Shih-Chieh Fuh, et al.
Published: (2023-01-01)

Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder
by: Sophie R. Vaccarino, et al.
Published: (2024-01-01)

Brazilian research on child and adolescent suicide: looking at the past to plan the future
by: Massimiliano Orri, et al.

Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report
by: Jacqueline K. Harris, et al.
Published: (2022-01-01)

Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
by: Victoria S. Marshe, et al.
Published: (2021-02-01)

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
by: Farhana Islam, et al.
Published: (2022-09-01)

Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study
by: Sondos Ayyash, et al.
Published: (2024-06-01)

A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
by: Anastasiya Slyepchenko, et al.
Published: (2023-09-01)

Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
by: Benjamin Schwartzmann, et al.
Published: (2023-05-01)

Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report
by: Pedro L. Ballester, et al.
Published: (2021-01-01)

Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
by: Caroline W. Espinola, et al.
Published: (2022-05-01)

Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes
by: Malosree Maitra, et al.
Published: (2023-05-01)

Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders
by: Anthony L. Vaccarino, et al.
Published: (2023-06-01)

Pro-inflammatory markers predict response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
by: M. I. Husain, et al.
Published: (2023-03-01)

Agitation Predicts Response of Depression to Botulinum Toxin Treatment in a Randomized Controlled Trial: the work of M. Alex Wollmer, et al. (2014)
by: Roumen eMilev
Published: (2015-04-01)

The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
by: Caroline J. K. Wallace, et al.
Published: (2021-02-01)

Multisite Comparison of MRI Defacing Software Across Multiple Cohorts
by: Athena E. Theyers, et al.
Published: (2021-02-01)

Add-on quetiapine for bipolar depression: twelve months open label prospective trial
by: Abraham Gaby, et al.
Published: (2006-02-01)

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study
by: Chinna Meyyappan, Arthi, et al.
Published: (2020-06-01)

Chromatin Profiling Techniques: Exploring the Chromatin Environment and Its Contributions to Complex Traits
by: Anjali Chawla, et al.
Published: (2021-07-01)

Systematic review of probiotics as an adjuvant treatment for psychiatric disorders
by: Evan Forth, et al.
Published: (2023-02-01)

Using electronically delivered therapy and brain imaging to understand OCD pathology: A pilot feasibility study
by: Callum Stephenson, et al.
Published: (2023-03-01)

Olfactory Functioning and Depression: A Systematic Review
by: Hannah Taalman, et al.
Published: (2017-09-01)

The effects of probiotics on depressive symptoms in humans: a systematic review
by: Caroline J. K. Wallace, et al.
Published: (2017-02-01)

Where did it all go wrong? Implementation failure - and more - in a field experiment of procedural justice policing
by: MacQueen, S, et al.
Published: (2016)

Enhancing public trust and police legitimacy during road traffic encounters: results from a randomised controlled trial in Scotland
by: MacQueen, S, et al.
Published: (2015)

Some methods for classification and analysis of multivariate observations /
by: 343597 MacQueen, J.

Naïve Justice in the Ancient Greek Novel
by: Bruce D. MacQueen
Published: (2016-12-01)

Catching a (Double-Strand) Break: The Rad51 and Dmc1 Strand Exchange Proteins Can Co-occupy Both Ends of a Meiotic DNA Double-Strand Break.
by: Amy J MacQueen
Published: (2015-12-01)

Towards Utopia or Irreconcilable Tensions? Thoughts on Intellectual Property, Human Rights and Competition Law
by: Hector L MacQueen
Published: (2005-12-01)

Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature
by: Marina Wakid, et al.
Published: (2023-12-01)

Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study
by: Arthi Chinna Meyyappan, et al.
Published: (2022-01-01)